| HLA-F |
HLA-F, HLA-5.4, HLAF: HLA class I histocompatibility antigen, alpha chain F prec |
CD1E |
CD1E, RP11-101J8.5-005, hCG_1640053: CD1e molecule |
15.840 |
Evidence |
|
| CD1B |
CD1B: T-cell surface glycoprotein CD1b precursor |
HLA-E |
HLA-E, XXbac-BPG34K20.2-001: MHC class Ib antigen |
15.840 |
Evidence |
|
| CD1B |
CD1B: T-cell surface glycoprotein CD1b precursor |
FCGRT |
FCGRT, FCRN: IgG receptor FcRn large subunit p51 precursor |
15.840 |
Evidence |
|
| CD1B |
CD1B: T-cell surface glycoprotein CD1b precursor |
HLA-F |
HLA-F, HLA-5.4, HLAF: HLA class I histocompatibility antigen, alpha chain F prec |
15.840 |
Evidence |
|
| CNTFR |
CNTFR: Ciliary neurotrophic factor receptor alpha precursor |
CTF1 |
CTF1: Cardiotrophin-1 |
15.840 |
Evidence |
|
| MYF6 |
MYF6: Myogenic factor 6 |
MXD4 |
MXD4, MAD4: Max-interacting transcriptional repressor MAD4 |
15.840 |
Evidence |
|
| MYF6 |
MYF6: Myogenic factor 6 |
ID4 |
ID4: DNA-binding protein inhibitor ID-4 |
15.840 |
Evidence |
|
| TNFRSF1B |
TNFRSF1B, TNFBR, TNFR2: Tumor necrosis factor receptor superfamily member 1B pre |
TNFSF9 |
TNFSF9: Tumor necrosis factor ligand superfamily member 9 |
15.840 |
Evidence |
|
| CTRB1 |
CTRB1, CTRB: Chymotrypsinogen B precursor |
SERPINB13 |
SERPINB13, PI13: Serpin B13 |
15.840 |
Evidence |
|
| TCF3 |
TCF3, E2A, ITF1: Transcription factor E2-alpha |
MYOG |
MYOG, MYF4: Myogenin |
15.840 |
Evidence |
O
|
| TCF4 |
TCF4, ITF2, SEF2: Transcription factor 4 |
MYOG |
MYOG, MYF4: Myogenin |
15.840 |
Evidence |
|
| TCF4 |
TCF4, ITF2, SEF2: Transcription factor 4 |
TAL1 |
TAL1, SCL, TCL5: T-cell acute lymphocytic leukemia protein 1 |
15.840 |
Evidence |
|
| TCF4 |
TCF4, ITF2, SEF2: Transcription factor 4 |
HAND2 |
HAND2, DHAND: Heart- and neural crest derivatives-expressed protein 2 |
15.840 |
Evidence |
|
| TCF4 |
TCF4, ITF2, SEF2: Transcription factor 4 |
MYF6 |
MYF6: Myogenic factor 6 |
15.840 |
Evidence |
|
| MYF5 |
MYF5: Myogenic factor 5 |
MXD4 |
MXD4, MAD4: Max-interacting transcriptional repressor MAD4 |
15.840 |
Evidence |
|
| MYF5 |
MYF5: Myogenic factor 5 |
ID4 |
ID4: DNA-binding protein inhibitor ID-4 |
15.840 |
Evidence |
|
| LYL1 |
LYL1: Protein lyl-1 |
ID3 |
ID3, 1R21, HEIR-1: DNA-binding protein inhibitor ID-3 |
15.840 |
Evidence |
|
| BCL2 |
BCL2: Apoptosis regulator Bcl-2 |
BCL2L2 |
BCL2L2, BCLW, KIAA0271: Apoptosis regulator Bcl-W |
15.840 |
Evidence |
|
| CD1A |
CD1A: T-cell surface glycoprotein CD1a precursor |
HLA-E |
HLA-E, XXbac-BPG34K20.2-001: MHC class Ib antigen |
15.840 |
Evidence |
|
| PROC |
PROC: Vitamin K-dependent protein C precursor |
SERPINE2 |
SERPINE2, PI7, PN1: Glia-derived nexin precursor |
15.840 |
Evidence |
|
| F2 |
F2: Prothrombin precursor |
CNTNAP2 |
CNTNAP2, CASPR2, KIAA0868: Contactin-associated protein-like 2 precursor |
15.840 |
Evidence |
|
| HAND1 |
HAND1, EHAND: Heart- and neural crest derivatives-expressed protein 1 |
TCF12 |
TCF12, HEB, HTF4: Transcription factor 12 |
15.840 |
Evidence |
O
|
| HAND1 |
HAND1, EHAND: Heart- and neural crest derivatives-expressed protein 1 |
TCF4 |
TCF4, ITF2, SEF2: Transcription factor 4 |
15.840 |
Evidence |
|
| SOCS5 |
SOCS5, CIS6, CISH5, CISH6, KIAA0671: Suppressor of cytokine signaling 5 |
LYN |
LYN: Tyrosine-protein kinase Lyn |
15.840 |
Evidence |
|
| SOCS5 |
SOCS5, CIS6, CISH5, CISH6, KIAA0671: Suppressor of cytokine signaling 5 |
PTK6 |
PTK6, BRK: Tyrosine-protein kinase 6 |
15.840 |
Evidence |
|